Walleye Capital’s LeonaBio Inc LONA Stock Holding History

Walleye Capital’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,572	Closed	-$1.43M	–	2348
2022 Q1	$1.43M	Buy	+10,572	New	+$1.11M	0.04%	475
2021 Q3	–	Sell	-4,642	Closed	-$475K	–	1585
2021 Q2	$475K	Buy	+4,642	New	+$810K	0.02%	768

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Walleye Capital's LONA Position: Q2 2022 in Review

Walleye Capital sold out of LeonaBio Inc (LONA) in Q2 2022, closing a stake of 10,572 shares — an estimated $1.43M sold.

Walleye Capital first reported a position in LONA in Q2 2021 and held it in 2 quarters. The position peaked at $1.43M in Q1 2022. 98 funds tracked by Wall St. Rank hold LONA as of Q2 2022.

Walleye Capital reported no remaining LeonaBio Inc position as of Q2 2022 after selling out during the quarter.
Walleye Capital sold 10,572 LeonaBio Inc shares in Q2 2022, an estimated $1.43M.
Walleye Capital first reported a position in LeonaBio Inc in Q2 2021 and held it in 2 quarters.
Walleye Capital's LeonaBio Inc position peaked at $1.43M in Q1 2022.
98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2022.

Based on Walleye Capital's 13F filing for Q2 2022, filed 8 Aug 2022.